Brief: Immuneonco Biopharmaceuticals Shanghai Gives Notice To Haitong ASM To Redeem HK$200 Million Product
16/06/2025 16:03
June 16 (Reuters) - ImmuneOnco Biopharmaceuticals Shanghai Inc 1541.HK: GIVEN NOTICE TO HAITONG ASM TO REDEEM HK$200 MILLION OF HAITONG PRODUCT ON JUNE 16, 2025 Further company coverage: 1541.HK ((Reuters.Briefs@thomsonreuters.com))
Recent news on ImmuneOnco Biopharmaceuticals (Shanghai)
See all newsBrief: Immuneonco Biopharmaceuticals (Shanghai) To Subscribe For Wealth Management Product For Hk$87.5 Million
Brief: ImmuneOnCo Biopharmaceuticals (Shanghai) To Repurchase H Shares In Open Market
Brief: Immuneonco Biopharmaceuticals (Shanghai)Subscribes For Hk$212 Million Wealth Management Product
Brief: Immuneonco Biopharmaceuticals Shanghai Inc Posts FY Loss Attributable RMB218.6 Million
Brief: ImmuneOnco Biopharmaceuticals Shanghai Receives Approval From NMPA China For Investigational New Drug Application Of IMM0306S